Presentation Number News Today

Investigators will present study highlighting a phosphoproteomic diagnostic for patient stratification of first line systemic hepatocellular carcinoma therapy LONDON, May 28, 2024 /PRNewswire/

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,...

Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients.Encouraging VAXI...

– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...

/PRNewswire/ -- GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody...

Investegate announcements from Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update

/PRNewswire/ -- Huahui Health Ltd.("Huahui Health"), a clinical stage biotechnology company focused on discovering and developing virology, hepatology, and...

PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the...

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers